212
Cancer of the Prostate: Molecular Genetics
Devgan, S.A., Henderson, B.E., Yu, M.C., et al.
(1997)
Genetic
variation
of
3
beta-
hydroxysteroid dehydrogenase type II in three
racial/ethnic groups: implications for prostate
cancer risk,
Prostate
33
, 9–12.
Dong, J.T.,
Isaacs, W.B.,
Isaacs, J.T.
(1997)
Molecular advances in prostate cancer,
Curr.
Opin. Oncol.
9
, 101–107.
Dong, J.T., Lamb, P.W., Rinker-Schaeffer, C.W.,
et al. (1995) KAI1, a metastasis suppressor
gene
for
prostate
cancer
on
human
chromosome 11p11.2,
Science
268
, 884–886.
Dong, J.T., Suzuki, H., Pin, S.S., et al. (1996)
Down-regulation
of
the
KAI1
metastasis
suppressor gene during progression of hu-
man prostatic cancer infrequently involved
gene mutation or allelic loss,
Cancer Res.
56
,
4387–4390.
Eagle, L.R., Yin, X., Brothman, A.R., et al. (1995)
Mutation of the MXI1 gene in prostate cancer,
Nat. Genet.
9
, 249–255.
Eastham, J.A., Truong, L.D., Rogers, E., et al.
(1995)
Transforming
growth
factor-beta-1:
comparative immunohistochemical localiza-
tion in human primary and metastatic prostate
cancer,
Lab. Invest.
73
, 628–635.
Edwards, A.,
Hammond, H.A.,
Jin, L.,
et al.
(1992) Genetic variation at Fve trimeric and
tetrameric tandem repeat loci in four human
population groups,
Genomics
12
, 241–253.
Egawa, S.,
Uchida, T.,
Suyama, K.,
et al.
(1995) Genomic instability of microsatellite
repeats in prostate cancer: relationship to
clinicopathological variables,
Cancer Res.
55
,
2418–2421.
Emmert-Buck, M.R., Vocke, C.D., Pozzatti, R.O.,
et al.
(1995) Allelic
loss
on
chromosome
8p12–21 in microdissected prostatic intraep-
ithelial neoplasia,
Cancer Res.
55
, 2959–2962.
Ewing, C.M., Ru, N., Morton, R.A., et al. (1995)
Chromosome 5 suppresses tumorigenicity of
PC3 prostate cancer cells: correlation with re-
expression of alpha-catenin and restoration
of
E-cadherin
function,
Cancer
Res.
55
,
4813–4817.
±earon, E.R., Vogelstein, B. (1990) A genetic
model for colorectal tumorigenesis,
Cell
16
,
759–767.
±eilotter, H.E., Nagai, M.A., Boag, A.H., et al.
(1998) Analysis of PTEN and the 10q23 region
in primary prostate carcinomas,
Oncogene
16
,
1743–1748.
±leming, W.H., Hamel, A., MacDonald, R., et al.
(1986) Expression of the c-myc protooncogene
in human prostatic carcinoma and benign
prostatic
hyperplasia,
Cancer
Res.
46
,
1535–1538.
±ossa, A.,
Lilleby, W.,
±ossa, S.D.,
Gauder-
nack, G., Torlakovic, G., Berner, A. (2002) In-
dependent prognostic signiFcance of HER-2
oncoprotein expression in pN0 prostate can-
cer undergoing curative radiotherapy,
Int. J.
Cancer
99
(1), 100–105.
±ournier, G., Latil, A., Amet, Y., et al. (1994)
Gene ampliFcations in advanced-stage human
prostate cancer,
Urol. Res.
22
, 343–347.
±owler, J.E., Lau, J.T., Ghosh, L., et al. (1988)
Epidermal
growth
factor
and
prostatic
carcinoma: an immunohistochemical study,
J. Urol.
139
, 857–861.
±
o
x
,
S
.
B
.
,P
e
r
s
a
d
,
R
.
A
.
,C
o
l
e
m
a
n
,N
.(
1
9
9
4
)
Prognostic value of c-erbB-2 and epidermal
growth factor receptor in stage A1 (T1a)
prostatic adenocarcinoma,
Br. J. Urol.
74
, 214.
±rixen, U.H.,
Behrens, J.,
Sachs, M.,
et al.
(1991) E-cadherin-mediated cell-cell adhesion
prevents invasiveness of human carcinoma
cells,
J. Cell Biol.
113
, 173–185.
±ukumoto, M.,
Shevrin, D.H.,
Roninson, I.B.
(1988)
Analysis
of
gene
ampliFcation
in
human tumor cell line,
Proc. Natl. Acad. Sci.
U.S.A.
85
, 6846–6850.
Gao, X., Honn, K.V., Grignon, D., et al. (1993)
±requent
loss
of
expression
and
loss
of
heterozygosity
of
the
putative
tumor
suppressor gene DCC in prostatic carcinomas,
Cancer Res.
53
, 2723–2727.
Gao, A.C., Lou, W., Dong, J.T., Isaacs, J.T. (1997)
CD44
is
a
metastasis
suppressor
gene
for
prostatic
cancer
located
on
human
chromosome 11p13,
Cancer Res.
57
, 846–849.
Gao, X., Wu, N., Grignon, D., et al. (1995) High
frequency of mutator phenotype in human
prostate cancer.,
Oncogene
9
, 2999–3003.
Gery, S., Koeffler, H.P. (2003) Repression of the
TME±±2 promoter by c-Myc,
J. Mol. Biol.
328
(5), 977–983.
Giovannucci, E.,
Stampfer, M.J.,
Krithivas, K.,
et al. (1997) The CAG repeat within the
androgen receptor gene and its relationship
to prostate cancer,
Proc.Natl.Acad.Sci.U.S.A.
94
, 3320–3323.
Giri, D.K.,
Wadhwa, S.N.,
Upadhaya, S.N.,
Talwar, G.P. (1993) Expression of NEU/HER-
2 oncoprotein (p185neu) in prostate tumors:
an immunohistochemical study,
Prostate
23
,
329–336.
previous page 886 Encyclopedia of Molecular Cell Biology and Molecular Medicine read online next page 888 Encyclopedia of Molecular Cell Biology and Molecular Medicine read online Home Toggle text on/off